HealthTree Logo HealthTree Foundation
Donate
HealthTree Logo
Donate
Personal Health Record
  • My Feed
  • Recently viewed

Learn

  • Topics
  • Events

Explore

  • Find treatments & trials
  • Participate in research
  • Find a coach
  • Find a specialist
  • Talk to a patient navigator
  • Get involved
  • For researchers
  • For healthcare providers
  • About us
  • Get involved
  • For researchers
  • For healthcare providers
  • About us

Create your Personal Health Record and unlock support built around you

Aligned with your diagnosis, treatment and where you are in your care. It lets HealthTree show you:

  • Treatments and trials you qualify for
  • Education for your stage of care
  • Financial support for your medications
  • Solutions to your side effects
Trial match for you
Matched on subtype and prior lines
Financial help
Support program for your current medication
Coach support
Coach suggestion with your same treatment path
Learn more about HealthTree
Trial match for you
Matched on subtype and prior lines
Financial help
Support program for your current medication
Coach support
Coach suggestion with your same treatment path
Video

BETA - What is GPRC5D? What makes it a good target in myeloma?

Posted by
HealthTree Logo HealthTree
• June 8, 2026

Description

What is GPRC5D? What makes it a good target in myeloma?

On this video

Healthtree contact Ajai Chari, MD

Ajai Chari, MD

Multiple Myeloma Specialist

Healthtree contact Mark Schroeder, MD

Mark Schroeder, MD

Multiple Myeloma Specialist

Related Content

  • Video Etentamig for Relapsed Multiple Myeloma: New Bispecific Shows Strong Results, Low CRS | IMS 2026
  • Video Can We Prevent Taste Loss with Talquetamab? TALISMAN Study Brings New Hope | EHA 2026
  • Video Talquetamab Steps Forward: MonumenTAL-3 - A New Potential for GPRC5D Therapy in Myeloma | EHA 2026
  • Video Lower Infections with Elranatamab in Multiple Myeloma in Real-World Settings | EHA 2026
  • Video BETA - What does the patient-reported quality of life data tell us about treatment with talquetamab?
  • Video BETA - What are possible explanations why a GPRC5D targeted therapy would stop working?